"Ospedale Generale Regionale "F. Miulli""

During the past decade, Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica" #1 collaborator was "Clinical Trials Promoting Group (APRIC/CTPG)" with 1 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 1 trials as a collaborator, "Gruppo Oncologico Italia Meridionale" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica(GOIRC)" with 1 trials as a collaborator and "Gruppo Oncologico del Lazio (GOL)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica" are "Ovarian Cancer" (2 trials), "Advanced Non-small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica" in a lesser frequency.

Most popular intervention types in "Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (2 trials), "gemcitabine" (2 trials), "capecitabine" (1 trials), "carboplatin" (1 trials) and "liposomal doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".